Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AVL 3288

Next Previous
Drug Profile

AVL 3288

Alternative Names: Anvylic-3288; AVL-3288; UCI-4083

Latest Information Update: 28 Mar 2018

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Anvyl Pharmaceuticals
  • Developer Anvyl
  • Class Neuroprotectants; Nootropics; Small molecules
  • Mechanism of Action Alpha7 nicotinic acetylcholine receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Cognition disorders

Highest Development Phases

  • No development reported Cognition disorders

Most Recent Events

  • 28 Mar 2018 No recent reports of development identified for phase-I development in Cognition-disorders(In volunteers) in USA (PO)
  • 16 Sep 2017 University of Maryland plans a phase I trial for Cognition disorders (NCT03281694)
  • 01 Nov 2016 New York State Psychiatric Institute and National Institute of Mental Health initiate a phase I trial for Cognition disorders associated with schizophrenia in USA (PO) (NCT02978599)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top